Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of December 2025
Lu @Allen
Free member

Location: New York, U.S.A.

Gender: Male

Market capitalization:

$1,721,998talents

Virtual portfolio value:

$1,721,998talents

Net overall return per annum:

8.68%

AYA current rank order:

#19

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
SMCI Super Micro Computer Inc. Common Stock $621.66 $940.44 300 +51.28% $95,634
ASML ASML Holding N.V. New York Registry Shares $560.79 $710.24 600 +26.65% $89,670
AMD Advanced Micro Devices Inc. Common Stock $140.15 $179.62 1,500 +43.60% $59,205
AMD Advanced Micro Devices Inc. Common Stock $140.15 $180.42 1,000 +44.24% $40,270
AAPL Apple Inc. Common Stock $148.32 $196.94 700 +32.82% $34,034
TSM Taiwan Semiconductor Manufacturing Company Ltd. $82.46 $102.12 1,500 +25.18% $29,490
ASML ASML Holding N.V. New York Registry Shares $560.79 $744.71 100 +32.80% $18,392
X United States Steel Corporation Common Stock $25.70 $31.25 2,000 +21.60% $11,100
AAPL Apple Inc. Common Stock $148.32 $197.96 200 +33.50% $9,928
TSM Taiwan Semiconductor Manufacturing Company Ltd. $82.46 $100.95 500 +23.74% $9,245
Sum $396,968

Top 10 current stock portfolio positions as of December 2025Strategy

Symbol Company Price Position Capitalization
MU Micron Technology Inc. Common Stock $241.14 3,400 $819,876
TSM Taiwan Semiconductor Manufacturing Company Ltd. $292.04 1,210 $353,368
MSFT Microsoft Corporation Common Stock $478.53 700 $334,971
NVDA NVIDIA Corporation Common Stock $175.02 790 $138,265
MRVL Marvell Technology Inc. Common Stock $84.43 690 $58,256
MSTR Strategy Inc Common Stock Class A $176.45 90 $15,880
Sum $1,720,616

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$NVDA $AAP
$MU
$ASML
$MRNA
$TSM

Blog+More

AT&T wins court approval to take over Time Warner with a trademark $85 billion bid despite the Trump prior dissent due to antitrust concerns.

Chanel Holden

2018-06-07 10:36:00 Thursday ET

AT&T wins court approval to take over Time Warner with a trademark $85 billion bid despite the Trump prior dissent due to antitrust concerns.

AT&T wins court approval to take over Time Warner with a trademark $85 billion bid despite the Trump administration prior dissent due to antitrust conce

+See More

Uniform field theory of corporate finance

Peter Prince

2022-11-25 09:29:00 Friday ET

Uniform field theory of corporate finance

Uniform field theory of corporate finance While the agency and precautionary-motive stories are complementary, these stories can be nested as special cas

+See More

The Economist offers a special report that the new normal state of economic affairs shines fresh light on the division of labor between central banks and governments.

Jonah Whanau

2019-11-15 13:34:00 Friday ET

The Economist offers a special report that the new normal state of economic affairs shines fresh light on the division of labor between central banks and governments.

The Economist offers a special report that the new normal state of economic affairs shines fresh light on the division of labor between central banks and go

+See More

The Federal Reserve proposes softening the Volcker rule that prevents banks from placing risky bets on securities with deposit finance.

James Campbell

2018-05-27 08:33:00 Sunday ET

The Federal Reserve proposes softening the Volcker rule that prevents banks from placing risky bets on securities with deposit finance.

The Federal Reserve proposes softening the Volcker rule that prevents banks from placing risky bets on securities with deposit finance. As part of the po

+See More

Amazon CEO Jeff Bezos admits the fact that antitrust scrutiny remains a primary imminent threat to his e-commerce business empire.

John Fourier

2019-04-17 11:34:00 Wednesday ET

Amazon CEO Jeff Bezos admits the fact that antitrust scrutiny remains a primary imminent threat to his e-commerce business empire.

Amazon CEO Jeff Bezos admits the fact that antitrust scrutiny remains a primary imminent threat to his e-commerce business empire. In his annual letter to A

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More